Latest News

American College of Allergy, Asthma, and Immunology Updates Guidance on Risk of Allergic Reactions to mRNA COVID-19 Vaccines

ARLINGTON HEIGHTS (Dec. 22, 2020) – Following reports of some patients experiencing anaphylaxis after getting a COVID-19 vaccine, the CDC has issued guidance related to COVID-19 vaccines and severe allergic reactions. Specifically, the CDC recommends patients experiencing a severe allergic reaction after getting the first shot should not get the second shot. The CDC also says that doctors may refer these patients to a specialist in allergies and immunology to provide more care or advice.

American College of Allergy, Asthma, and Immunology Releases Guidance on Risk of Allergic Reactions to the Pfizer-BioNTech COVID-19 Vaccine

ARLINGTON HEIGHTS (Dec. 14, 2020) – With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine. These recommendations are based on best knowledge to date but could change at any time, pending new information and further guidance from the FDA or CDC.